Oncotelic Therapeutics (OTLC)
OTHER OTC:OTLC
US Market
Holding OTLC?
Track your performance easily

Oncotelic Therapeutics (OTLC) Financial Statements

79 Followers

Oncotelic Therapeutics Financial Overview

Oncotelic Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.003; its P/E ratio is -9.35; Oncotelic Therapeutics is scheduled to report earnings on November 18, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue---$ 70.00K-
Gross Profit---$ 70.00K-
EBIT$ -72.95K$ 81.44K$ -655.63K$ 226.49K$ -6.65M
EBITDA$ -8.61K$ 119.45K$ -353.71K$ 226.49K$ -6.56M
Net Income Common Stockholders$ -209.84K$ -408.68K$ -735.97K$ 115.30K$ -6.76M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 72.22K$ 188.99K$ 170.41K$ 268.02K$ 181.87K
Total Assets$ 29.94M$ 29.97M$ 30.01M$ 30.10M$ 30.01M
Total Debt$ 0.00$ 0.00$ 12.57M$ 0.00$ 0.00
Net Debt$ -72.22K$ -188.99K$ 12.40M$ -268.02K$ -181.87K
Total Liabilities$ 18.43M$ 18.73M$ 18.40M$ 6.18M$ 5.61M
Stockholders Equity$ 12.16M$ 11.83M$ 12.13M$ 12.55M$ 12.32M
Cash Flow-
Free Cash Flow$ -261.77K$ -231.42K$ -421.05K$ -248.85K$ -448.56K
Operating Cash Flow$ -261.77K$ -231.42K$ -421.05K$ -248.85K$ -448.56K
Investing Cash Flow-----
Financing Cash Flow$ 145.00K$ 250.00K$ 275.00K$ 335.00K$ 440.00K
Currency in USD

Oncotelic Therapeutics Earnings and Revenue History

Oncotelic Therapeutics Debt to Assets

Oncotelic Therapeutics Cash Flow

Oncotelic Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis